Introduction {#sec1-1}
============

Visceral leishmaniasis (VL), a systemic parasitic vector borne disease, is prevalent in low-altitude areas having river belts attributing to preferential habitat of its vector, i.e. sand fly. It does rarely occur in altitudes over 2000 ft (600 m).\[[@ref1]\] However, in the last quarter of the twentieth century, migration of disease has been noticed and new niches being reported from previous non-endemic regions. One of them is across the Himalayas (Southern) from Pakistan to Bhutan through India. Considering Uttarakhand Himalayas of India, sporadic cases have been reported from the natives of Himalayan region such as Kumaon (350--900 m above mean sea level) and Garhwal (1500--2500 m above mean sea level) region.\[[@ref2][@ref3]\] This phenomenon of migrations of the disease from Indian endemic locality such as Bihar and West Bangel towards the hilly regions of Himalayas points towards the new endemicity of the disease.

The disease pattern of this region also varies slightly from rest of the world as documented in the few published case reports/series. Almost all cases present as VL rather than cutaneous leishmaniasis, and the common association of VL and hemophagocytic lympho-histiocytosis (HLH) syndrome is being found.\[[@ref4]\] HLH-associated VL is more malignant and difficult to diagnose as features of both overlap and lead to delayed treatment. Both require aggressive and early treatment for better outcomes in terms of morbidity and mortality.

This needs a study to know the demography and clinical details of VL patients in this so-called non-endemic area. Thereby, we do a cross-sectional hospital-based study of all adult VL cases who are coming from Uttarakhand state of India and admitted in our hospital (General Medicine Department) during the last two years.

Materials and Methods {#sec1-2}
=====================

This cross-sectional study was conducted during July 2017 to June 2019 in a referral 1000-bedded tertiary health center in Rishikesh, located in the base of Uttarakhand (state full of Himalayas), India.

Case records of all patients (*n* = 10) with VL (confirmed diagnosis), admitted to the Department of General Medicine of the hospital in the last two years, were scrutinized. Seven patients were included in the study after the inclusion criteria of Uttarakhand residential address.

The demographic, clinical, laboratory, treatment, and outcome details of all seven patients were entered in a systematic master chart excel. HLH was diagnosed based on diagnostic criteria and HScore calculated by online software *<http://saintantoine.aphp.fr/score>* predicted the percentage of possibility of HLH \[[Table 1](#T1){ref-type="table"}\].\[[@ref5][@ref6]\] Diagnosis of acute kidney injury (AKI) was made based on the KDIGO definition. Either or both hyperbilirubinemia (total bilirubin \>2.5 mg/dL) and transaminase elevation (more than twice the upper limit of normal) were used to classify as acute liver injury (ALI) after excluding the prior history of liver diseases.

###### 

HLH diagnostic criteria and online software version to predict HLH\[[@ref5][@ref6]\]

  ------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------
  At least five of the following eight findings required for diagnosis:\                                                                Following points are considered in online score calculation:\
  Fever ≥38.5°C\                                                                                                                        Known underlying immunodepression\
  Splenomegaly\                                                                                                                          Yes\
  Peripheral blood cytopenia, with at least two of the following:\                                                                       No\
   Hemoglobin \<9 g/dl (for infants \<4 weeks, haemoglobin \<10 g/dl for others)\                                                       Maximal Temperature (C)\
   Platelets \<100,000/microL\                                                                                                           Unknown\
   Absolute neutrophil count \<1000/microL\                                                                                              Less than 38.4 C\
  Hypertriglyceridemia (fasting triglycerides \>265 mg/dL) and/or hypofibrinogenemia (fibrinogen \<150 mg/dL)\                           38.4-39.4 C\
  Hemophagocytosis in bone marrow, spleen, lymph node, or liver\                                                                         \>39.4 C\
  Low or absent NK cell activity\                                                                                                       Hepatomegaly\
  Ferritin \>500 ng/mL (\>3000 ng/mL as more indicative of HLH)\                                                                         Unknown\
  Elevated soluble CD25 (soluble IL-2 receptor alpha \[sIL-2R\]) two standard deviations above age-adjusted laboratory-specific norms    Yes\
                                                                                                                                         No\
                                                                                                                                        Splenomegaly

                                                                                                                                         Unknown

                                                                                                                                         Yes

                                                                                                                                         No

                                                                                                                                        Lower Hemoglobin level

                                                                                                                                         Unknown

                                                                                                                                         Less than equal to 9.2 gm/dl

                                                                                                                                         More than 9.2 gm/dl

                                                                                                                                        Lower Leucocytes count

                                                                                                                                         Unknown

                                                                                                                                         Less than equal to 5000

                                                                                                                                         More than 5000

                                                                                                                                        Lower Platelets count

                                                                                                                                         Unknown

                                                                                                                                         Less than equal to 11,000

                                                                                                                                         More than11,000

                                                                                                                                        Higher Ferritin level (ng/ml)

                                                                                                                                         Unknown

                                                                                                                                         Less than equal to 2000

                                                                                                                                         Between 2000 to 6000

                                                                                                                                         More than 6000

                                                                                                                                        Higher Triglyceride level (mmol/L)

                                                                                                                                         Unknown

                                                                                                                                         Less than 1.5

                                                                                                                                         Between 1.5 and 4

                                                                                                                                         More than 1.5

                                                                                                                                        Lower Fibrinogen level (g/L)

                                                                                                                                         Unknown

                                                                                                                                         Less than or equal to 2.5

                                                                                                                                         More than 2.5

                                                                                                                                        Higher SGOT/AST level (U/L)

                                                                                                                                         Unknown

                                                                                                                                         Less than 30

                                                                                                                                         More than or equal to 30

                                                                                                                                        Hemophagocytosis features on bone marrow aspirate

                                                                                                                                         Unknown

                                                                                                                                         Yes

                                                                                                                                         No
  ------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------

Results {#sec1-3}
=======

During the last two years, we found seven cases of VL proven by rk-39 (point of care test for leishmaniasis) and later confirmed by bone marrow examination. Majority of them (except few having atypical features) presented with prolonged (\>1 months) high-grade fever with chills, rigors, malaise, anorexia, and unintentional weight loss without the history of any localizing symptoms \[[Table 2](#T2){ref-type="table"}\]. None of them gave any history of IV drug abuse, exposure to STDs, or travel to endemic region of VL (within a period of 1 year). Most of them had pancytopenia and hepato-splenomegaly.

###### 

Clinical characteristics of seven cases of visceral leishmaniasis

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  case   Age/sex      Occupation                                       Height from sea level (ft)   Duration of illness         Symptoms and signs other than fever, anorexia, and weight loss   Treatment                                                                                                             Outcome
  ------ ------------ ------------------------------------------------ ---------------------------- --------------------------- ---------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------
  1      28/male      Auto driver                                      4436                         1 month                     Pallor\                                                          Liposomal amphotericin B (10 mg/kg single dose)                                                                       Improved
                                                                                                                                Hepatosplenomegaly\                                                                                                                                                                    
                                                                                                                                B/L pleural\                                                                                                                                                                           
                                                                                                                                Effusion\                                                                                                                                                                              
                                                                                                                                Ascites                                                                                                                                                                                

  2      40/female    Housewife                                        5740                         6 months                    Jaundice\                                                        Started with plain amphotericin B, but because of anaphylactoid reaction, switched to liposomal, with dose 10 mg/kg   Improved
                                                                                                                                Hepatosplenomegaly\                                                                                                                                                                    
                                                                                                                                B/L pitting leg edema\                                                                                                                                                                 
                                                                                                                                B/L pleural\                                                                                                                                                                           
                                                                                                                                Effusion\                                                                                                                                                                              
                                                                                                                                Ascites                                                                                                                                                                                

  3      26 y/male    Mason\                                           1030                         4 ½ months                  Pallor\                                                          Liposomal amphotericin B (10 mg/kg single dose)                                                                       Improved
                      Contact with co-worker coming from West-Bengal                                                            Dragging sensation in left upper abdomen\                                                                                                                                              
                                                                                                                                Massive splenomegaly\                                                                                                                                                                  
                                                                                                                                Hepatomegaly                                                                                                                                                                           

  4      35/male      Labourer                                         1030                         First illness - 4 months\   Loose stool\                                                     First episode - plain amphotericin B (1 mg/kg, 14 days)\                                                              Improved
                                                                                                    Relapse - 1 week            Recurrent vomiting\                                              Second episode - Liposomal amphotericin B (10 mg/kg - single dose) and 14 days course of plain amphotericin B         
                                                                                                                                Massive splenomegaly                                                                                                                                                                   

  5      61/male      Retired postman                                  5413                         3 months                    Pallor\                                                          Liposomal amphotericin B (10 mg/kg single dose)                                                                       Improved
                                                                                                                                Jaundice\                                                                                                                                                                              
                                                                                                                                Hepatosplenomegaly\                                                                                                                                                                    
                                                                                                                                Breathlessness                                                                                                                                                                         

  6      34y/female   Housewife                                        3000                         5-6 months                  Bleeding lips\                                                   Liposomal amphotericin B (3 mg/kg/day for 5 days and then on day 14 and 21)                                           Improving trend, but during second blood transfusion developed breathlessness and irreversible cardiac arrest
                                                                                                                                Epistaxis\                                                                                                                                                                             
                                                                                                                                Breathlessness\                                                                                                                                                                        
                                                                                                                                Jaundice\                                                                                                                                                                              
                                                                                                                                Pallor B/L pitting leg edema                                                                                                                                                           

  7      45/male      Labour\                                          1030                         4-5 months                  Pallor\                                                          Liposomal amphotericin B (10 mg/kg single dose)                                                                       Improved
                      Contact with co-worker coming from Bihar                                                                  Hepatosplenomegaly                                                                                                                                                                     
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Other local causes of prolonged fever like malaria, enteric fever, scrub typhus, tuberculosis, HIV, HCV, and HBV were ruled out except case 7 that had HBsAg positive. Bone marrow examinations showed LD bodies confirming VL \[[Table 3](#T3){ref-type="table"}\]. During further evaluation, serum ferritin and triglyceride were found to be raised, so possibility of HLH syndrome was suspected and HScore calculated. All had \>90% probability of HLH (secondary to VL). However, NK cell activity and sCD25 level could not be done due to unavailability. Final diagnosis of VL with secondary HLH was considered. All cases except one improved after treatment with either plain amphotericin-B (never alone) and or liposomal amphotericin-B depending upon affordability and preferences. Positive response was considered to have informed of absence of fever, decrease in spleen size, and improving hematological parameters. All were discharged on due course and doing well on follow up except one who died during hospital course.

###### 

Laboratory (initial) characteristics of seven cases diagnosed as visceral leishmaniasis

  Parameters                            1                                                                                                           2                                                                  3                    4                                5                                6                    7
  ------------------------------------- ----------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------ -------------------- -------------------------------- -------------------------------- -------------------- --------------------------------
  Hemoglobin (gm%)                      7.8                                                                                                         9.6                                                                7.0                  10.6                             6.7                              6.2                  8.08
  Total leukocyte count (cells/mm^3^)   2500                                                                                                        2290                                                               2200                 1500                             3000                             4200                 3.500
  Platelets                             50,000                                                                                                      1.2 lakh                                                           21,000               63,000                           42,000                           35,000               1.23 lakh
  Total bilirubin (mg/dL)               1.15                                                                                                        2.1                                                                1.2                  1.05                             2.46                             4.3                  0.54
  Direct bilirubin (mg/dL)              0.52                                                                                                        0.4                                                                0.13                 0.21                             1.22                             1.2                  0.25
  Serum albumin/globulin (mg/dL)        2.13/3.7                                                                                                    2.78/2.68                                                          2.5/3.12             3.1/4.1                          2.1/3.7                          1.9/3.2              3.74/4.85
  AST (IU)                              734                                                                                                         385                                                                57                   65                               136                              98                   80
  ALT (IU)                              651                                                                                                         152                                                                245                  156                              412                              132                  116
  Urea/creatinine (mg/dl)               45/0.56                                                                                                     40/1.12                                                            56/0.9               51/2.36                          25/0.72                          46/2.3               36/0.5
  Triglycerides (mg/dl)                 251                                                                                                         219                                                                266                  239                              242                              342                  Unknown
  Serum ferritin (ng/dl)                \>1650                                                                                                      \>1650                                                             \>1650               \>1650                           \>1650                           \>1650               \>1650
  USG - abdomen                         Hepatosplenomegaly, mild bilateral pleural effusion, and ascites with subcentimetric abdominal lymphnodes   Hepatosplenomegaly, mild bilateral pleural effusion, and ascites   Hepatosplenomegaly   Hepatosplenomegaly               Hepatosplenomegaly               Hepatosplenomegaly   Hepatosplenomegaly
  BM findings                           Leishman Donovan (LD) bodies                                                                                LD bodies and hemophagocytosis                                     LD bodies            LD bodies and hemophagocytosis   LD bodies and hemophagocytosis   LD bodies            LD bodies and hemophagocytosis
  HScore                                219/96.03%                                                                                                  238/96.74%                                                         235/98.49%           225/97.23%                       243/99.076%                      219/96.03%           235/98.4%

Few atypical findings were observed. All cases had liver involvement in the form of transaminitis and three had jaundice. Two cases had anasarca and kidney injury. One had gastrointestinal manifestation. Although case 6 had been diagnosed as VL 4- 5 months before by haematology department, but she deferred treatment and after 2 months she presented with intermittent bleeding lips and progressive anasarca. She developed transfusion reaction after the transfusion of packed RBC with acute lung injury and suddenly went to irreversible cardiac arrest.

Discussion {#sec1-4}
==========

The present study focuses on cases, presenting as fever of unknown origin (FUO) from hilly regions of Southern Indian Himalayas, and later on unexpectedly proven to be VL. These cases were native of Uttarakhand (mainly areas near the river belts, especially Ganga), neither visited to endemic zone nor having any contacts with people of that zone except case 3 and 7 having h/o contact with Bengali and Bihari laborers, suggesting the possibility of expansion of endemicity \[[Figure 1](#F1){ref-type="fig"}\]. All cases were proven to have HLH (\>95% chance based on Hscore) and liver involvement. Hence, expansion of disease territory and variation in disease manifestations are more concern.

![Terrain map showing distribution of seven visceral leishmaniasis cases (in orange colored) and previous published studies (in blue colored) in Uttarakhand Himalayas and trace of river Ganga along with endemic locations (inlet, Indian map having colored states: Uttar Pradesh, Bihar, Jharkhand, and West Bengal) of leishmaniasis. Map courtesy: Terrain map scaled down from Google Map^R^ -- modified in compliance with in-app permissions and policies](JFMPC-9-1362-g001){#F1}

Previous case reports of VL from different regions of Uttarakhand are mainly distributed along the banks of river Ganges \[[Table 4](#T4){ref-type="table"}\].\[[@ref2][@ref3][@ref7][@ref8][@ref9][@ref10][@ref11][@ref12]\] But there is lack of data and research regarding whether the parasite and its vector have developed as a new species in these areas or introduced de novo by migrant population. Although the latter appears more likely, as one study suggests the possibility of ecological changes causing an environmental shift in favor of vector proliferation, due to the development of Tehri dam reservoir and migration of laborers from endemic areas.\[[@ref3]\] Also, the possibility of the upstream move of sandflies along the Ganges from endemic zone cannot be excluded as has been suspected in our study in the map. Each primary care physicians should consider this possibility now in this non-endemic region.

###### 

Summary of published articles on leishmaniasis in Uttarakhand Himalayas\[[@ref2][@ref3][@ref7][@ref8][@ref9][@ref10][@ref11][@ref12]\]

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Citations                  Sample size                                 Location                                                                 Agent details                        Host details                                                                                                                                                                        Vector details                                                                                                           Environmental factors studied                                                                                                                                                                     Nearby river   Authors Conclusion
  -------------------------- ------------------------------------------- ------------------------------------------------------------------------ ------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ahmad S, *et al*. 2016     33 (excludes 14 pediatric cases as below)   Garhwal region of Uttarakhand (India)                                    Leishmania, species not identified   CP: VL - prolonged fever, hepato-splenomegaly, pancytopenia, negative HIV status, and Hemophagocytosis. Rx: Sodium stibogluconate, both types of amphotericin-B, and miltefosine\   Not documented                                                                                                           Altitude: 1500-4000 m above sea level.\                                                                                                                                                           Ganges         The protozoan is de novo from Uttarakhand. However, molecular mapping is needed to confirm the ancestry.
                                                                                                                                                                                       Outcome: one relapse and cured with lip amph-B. Survival of all cases except one who succumbs.                                                                                                                                                                                                               The patients had never visited any of the endemic areas.\                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Development of Tehri dam reservoir, migration of labors from Bihar and endemic areas, and the ecological changes have apparently caused an environmental shift in favor of vector proliferation                  

  Bhatt NK, *et al*. 2016    14                                          Garhwal region of Uttarakhand (India)                                    Leishmania, species not identified   CP: VL - prolonged fever, hepato-splenomegaly, lymphadenopathy, pancytopenia, negative HIV status, and Hemophagocytosis (HLH - 7 cases).\                                           Not documented                                                                                                           -do-                                                                                                                                                                                              -do-           The protozoan appears to have established a local transmission cycle, although local vector and probably an animal reservoir remain elusive.\
                                                                                                                                                                                       Rx: Sodium stibogluconate Outcome: Survival of all cases except one who succumbs before starting the treatment.                                                                                                                                                                                                                                                                                                                                                                                                               Epidemiological studies are needed to identify the vector and animal reservoir if any.

  Chandra H, *et al*. 2014   Seven                                       Different areas of Uttarakhand (India)                                   Leishmania, species not identified   CP: VL - fever, hepato-splenomegaly, hemophagocyticlymphohistioctosis (HLH) syndrome.\                                                                                              Not documented                                                                                                           Altitude??                                                                                                                                                                                        Ganges         In all HLH cases, leishmaniasis should be suspected.\
                                                                                                                                                                                       Rx: plain Amphotericin B\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     HLH diagnosis criteria may be modest while applied.\
                                                                                                                                                                                       Outcome: Survival of all cases.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               VL with HLH respond well to amphotericin.

  Mathur SB, *et al*. 2014   Six                                         Nainital (3), Champawat (1) and Pithoragarh (2) of Uttarakhand (India)   Leishmania, species not identified   CP: VL - prolonged fever, hepato-splenomegaly, pancytopenia.\                                                                                                                       Not documented                                                                                                           Altitude: 258-1760 m from sea level.\                                                                                                                                                             Ganges         Highlight the changing geographic distribution and the need for detailed epidemiological surveys in nonendemic regions for assessing the impact of climate change and the possibility of a zoonotic reservoir of VL in India.
                                                                                                                                                                                       Rx: Liposomal (4 cases) and plain (2 cases) Amphotericin B\                                                                                                                                                                                                                                                  Patients never traveled to or migrated from endemic areas.                                                                                                                                                       
                                                                                                                                                                                       Outcome: 5 survived and 1 death                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Kumar A, *et al*. 2013     10                                          Kumaon region of Uttarakhand (India)                                     Leishmania, species not identified   CP: VL - fever, hepato-splenomegaly, weight loss, and pancytopenia.\                                                                                                                Not documented                                                                                                           -do-                                                                                                                                                                                              Ganges         Highlights the changing geographic distribution and spread with implications for its control as a public health problem.\
                                                                                                                                                                                       Rx: Intravenous sodium\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Epidemiological work is required in this area to substantiate the presence or absence of any zoonotic reservoir.
                                                                                                                                                                                       Stibogluconate (2, then shifted to ampho due to failure), Lip ampho-B\                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                       Outcome: Survival (6 cases), lost to follow up (3), and death (1)                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Verma SK, *et al*. 2007    Nine                                        Garhwal region of Uttarakhand (India)                                    Leishmania, species not identified   CP: prolonged fever, hepato-splenomegaly, pancytopenia and hypergammaglobulinaemia. Rx: Sodium stibogluconate Outcome: Survival of all cases                                        Preponderance of Phlebotomusargentipes (77%), which is mainly confined to cattle sheds and mixed dwellings in villages   Altitude: 1500-4000 m above sea level.\                                                                                                                                                           Ganges         Sodium stibogluconate-sensitive VL is emerging in the non-endemic\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    The patients had never visited any of the endemic areas.                                                                                                                                                         Garhwal region, India, and urgent and effective vector control measures may be warranted to prevent the disease from becoming a major health problem in this region.

  Rao JS, *et al*. 2001      None                                        Kumaon region (Almora&Nainital) of Uttarakhand (India)                   Not applicable                       Not applicable                                                                                                                                                                      Ph. argentipes (77%), Ph. papatasi (6.9%), Ph. major (2.9%), and sergentomyia (13.2%)                                    -do-                                                                                                                                                                                              Ganges         Ph. argentipes mainly confined to cattle sheds and mixed dwellings in the villages, mainly zoophilic, and highly susceptible to DDT (mortality, 98-100%).

  Singh S, *et al*. 1999     Five                                        Kumaon region (Almora and Nainital) of Uttarakhand (India)               Leishmania, species not identified   CP: VL - fever, hepato-splenomegaly, weight loss, and pancytopenia.\                                                                                                                Not documented                                                                                                           Altitude: 350-960 meters from sea level.                                                                                                                                                          Ganges         This advices for further research into the epidemiology of vector and warns about the emerging pattern in non-endemic areas.
                                                                                                                                                                                       Rx: Intravenous sodium\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                       Stibogluconate\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                       Outcome: Survival of all cases except one death                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Clinical presentation of cases varies compared to endemic cases. For example, most of the cases till now, reported from this area, are of VL rather than cutaneous leishmaniasis similar to our study. Liver function derangement is infrequent in VL although the parasite primarily infects the reticuloendothelial system and hepatomegaly is common. In previous Indian studies, biochemical evidence of hepatitis was found in 25%, 17%, and 51% of VL patients, respectively.\[[@ref13][@ref14]\] In our study, 43% had direct hyperbilirubinemia, 70% had hypoalbuminemia, and all had transaminitis (100%), although none had evidence of other causes of hepatitis except case 7 having positive HBsAg. This 100% liver involvement could be a part of HLH since all of our cases had the same. This supports HLH goes hand in hand with VL in this region.

VL is one of the major infective causes of HLH. The clinical picture of both is often overlapping and bone marrow may fail to reveal LD bodies. Consequently, VL might be missed and intense immunosuppression for HLH without specific antimicrobial therapy may be administered with disastrous consequences. Till date only few cases have been reported to have this combination.\[[@ref4]\] In our study, all cases have strong association with HLH. If it comes true, we need aggressive approach for VL in these areas since the main treatment of secondary HLH is the treatment of primary cause. This will help all clinicians in this region to work up for HLH in the suspected cases of VL and vice versa. The common association is yet to be studied on large database so as to conclude the exact relationship and association between the two.

Kidney involvement is also unusual in VL. According to a prospective study, kidney impairment found in 11% cases of VL, but in our study, two cases (27%) had AKI (case 4 and 7).\[[@ref15]\] We could not find out the exact cause of AKI, but case 4 had diarrhea (pre-renal AKI). We need further detail study and more data to conclude the cause. VL-associated lymphadenopathy is seen in hilly area as per one study, but our study could not establish this relationship.\[[@ref16]\] Case no 6 had epistaxis and bleeding lips, mostly due to thrombocytopenia or deficient clotting factor as suggested by Sigdel *et al*.\[[@ref17]\] Bilateral pleural effusion is also a very rare finding in immunocompetent VL cases and has been reported only in few cases from endemic cases.\[[@ref18]\]

Treatment for VL and associated HLH is mainly amphotericin-B either as a single dose of liposomal one or multiple doses of plain one.\[[@ref19]\] An efficacy of 95.7% is seen with a single-dose regimen of liposomal amphotericin B at a dose of 10 mg/kg, along with the lower toxicity and shorter duration of therapy. However, multiple doses of 18--21 mg/kg plain amphotericin-B have 90%--100% efficacy in southern Europe with many adverse effects, which necessitate close monitoring and hospitalization for 4--5 weeks, which ultimately increases the cost of therapy. Amphotericin-B may inhibit macrophage function, cytokine expression, antigen-induced proliferation of T and B cells *in vitro*, and the function of cytotoxic T cells. Therefore, it may have exerted a dual effect on both HLH and VL in our study. All our cases respond to liposomal molecule including one case that failed from plain amphotericin-B. This suggests importance of liposomal over plain amphotericin-B, especially a note for physicians in this community.

Our study had its own set of limitations. First, this study was of small sample size and short follow up. However, in a non-endemic area, this may be significant. Second, the data collected were dependent on medical records. Third, our work is based on the characteristics of the study population, which was from a tertiary care center and most likely represents a more severe disease spectrum. Therefore, the disease prevalence might have been underestimated. Lastly, the study did not account negative diagnostic test results during the study period. Since pointers to think for VL/HLH depend upon experiences of concerned doctors of this study, good documentation quality and knowledge capacity of the doctors are to be taken care in future studies to answer this question. Findings in our study are similar to few studies done before, adding validity to the data.\[[@ref20]\] Since this study was done in non-endemic zone for VL, the result is valid to whole Himalayas where VL may be a rising threat. This may serve as a benchmark for further epidemiological study for case detection.

In summary, in cases presenting with FUO from hilly regions of Uttarakhand, VL should be considered as one of the differentials. It is alarming that so-called non-endemic areas for VL are converting to endemic zone. The possible reason may be migration of vectors along the upstream belts of Gange. High index of suspicion of VL is to be kept in cases of HLH and vice versa. Similarly, liver involvement is to be considered in VL/HLH cases and vice versa. Kidney involvement is seen in one-third of the VL cases. Liposomal amphotericin-B is recommended over plain one in VL cases in this region. Furthermore, VL cases should further be subject to comparison with those found in other endemic parts of India so as answer and fill the gap of knowledge about increasing prevalence and variances of VL in this region.
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